U.S. Oil and Gas Stock News

NasdaqGS:ADI
NasdaqGS:ADISemiconductor

Is Analog Devices (ADI) Pricing In Too Much Optimism After Its Recent Share Price Surge

If you are wondering whether Analog Devices at around US$402 per share looks expensive or attractive, the answer depends on how you think about value, not just price. The stock has been volatile recently, with a 0.4% decline over the last 7 days, but a 26.4% gain over 30 days, 46.9% year to date, and returns of 110.8% over 1 year, 133.3% over 3 years, and 182.1% over 5 years. Recent coverage has focused on Analog Devices as a key name in semiconductors, with attention on how its technology...
NYSE:MANU
NYSE:MANUEntertainment

Manchester United (NYSE:MANU) Valuation Check As Recent Share Gains Meet Mixed Pricing Signals

Recent share performance snapshot Manchester United (NYSE:MANU) has seen its share price move recently, with a last close of US$18.88. Over the past month and the past 3 months, the stock has recorded total returns of 12.2% and 6.7% respectively. See our latest analysis for Manchester United. For context, the recent 1 month share price return of 12.2% and year to date share price return of 19.65% sit alongside a 1 year total shareholder return of 37.11%, while the 3 year total shareholder...
NYSE:ASAN
NYSE:ASANSoftware

A Look At Asana (ASAN) Valuation As Short Squeeze Interest And Waning Selling Pressure Attract Fresh Attention

Why a potential short squeeze is putting Asana (ASAN) on watch Asana (ASAN) is drawing renewed attention after analysis highlighted short interest above 30% and a relatively tight float, given founder Dustin Moskovitz’s large controlling stake. Together, these factors raise the potential for a short-squeeze setup. See our latest analysis for Asana. Despite renewed interest around a potential short squeeze and recent board changes taking effect at the June 2026 annual meeting, Asana’s 1-year...
NYSE:LUMN
NYSE:LUMNTelecom

Lumen’s Legal and Public Sector Shake-Up Might Change The Case For Investing In Lumen (LUMN)

Lumen Technologies announced that Executive Vice President and Chief Legal Officer & Head of Public Sector Mark Hacker has retired to pursue ministry, with Senior Vice President Jennifer Hodges promoted to Executive Vice President and Chief Legal Officer and Jeff Sharritts assuming Public Sector responsibilities as of April 20, 2026. This reshuffle consolidates legal, governance, and public sector oversight under leaders with deep corporate and telecom experience, potentially influencing how...
NasdaqCM:HYMC
NasdaqCM:HYMCMetals and Mining

A Look At Hycroft Mining (HYMC) Valuation After Major Resource Upgrade And Project Progress

Hycroft Mining Holding (HYMC) is back in focus after Q1 2026 results highlighted a 55% increase in measured and indicated gold and silver resources, alongside continued work on underground mining options in Nevada. See our latest analysis for Hycroft Mining Holding. The stock has been volatile around these updates, with a 6.6% 1 day share price return and a 49.4% year to date share price return, while the 1 year total shareholder return is very large. Recent exploration and resource news...
NYSE:BX
NYSE:BXCapital Markets

Blackstone Extends Reach Into Life Sciences And AI Data Infrastructure

Blackstone (NYSE:BX) committed up to US$400 million to Teva's autoimmune drug program in a recent life sciences deal. The firm also arranged a US$2 billion, utility backed power financing package for QTS data centers to support AI focused capacity. These transactions sit alongside Blackstone's traditional alternatives platform and indicate additional sector exposure in health and digital infrastructure. For investors, these moves illustrate how NYSE:BX is putting capital to work in areas...
NYSE:WBS
NYSE:WBSBanks

Assessing Webster Financial (WBS) Valuation After Q1 2026 Earnings And Dividend Reaffirmation

Q1 earnings and dividend decision set the tone for Webster Financial Webster Financial (WBS) has just combined fresh first quarter 2026 results with a reaffirmed cash dividend, giving you updated information on earnings quality, balance sheet trends, and ongoing capital returns. See our latest analysis for Webster Financial. Webster Financial's recent first quarter earnings and dividend announcement come after a 10.02% 90 day share price return and a 55.60% total shareholder return over the...
NasdaqGS:ON
NasdaqGS:ONSemiconductor

Evaluating ON Semiconductor (ON) After New Geely And NIO Electric Vehicle Partnerships

ON Semiconductor (ON) is back in focus after deepening its collaborations with automakers Geely and NIO, which are integrating the company’s EliteSiC power technologies into high voltage electric vehicle platforms. See our latest analysis for ON Semiconductor. These EV collaborations are landing at a time when momentum in ON Semiconductor’s shares is already strong, with a 30 day share price return of 62.81% and a 1 year total shareholder return of 154.57% pointing to shifting expectations...
NasdaqGS:NAVN
NasdaqGS:NAVNHospitality

Is Navan (NAVN) Share Price Moves Justified By Current Growth Assumptions

If you are wondering whether Navan is fairly priced or offering hidden value at its current level, it helps to look beyond the headline share price and into what different valuation methods are signaling. Navan’s stock recently closed at US$17.49, with returns of 12.9% over the past 7 days, 32.1% over the past 30 days, and 7.6% year to date. This performance has likely caught the attention of investors watching for changes in sentiment and risk appetite. These moves sit against a backdrop...
NasdaqGS:RPRX
NasdaqGS:RPRXPharmaceuticals

Royalty Pharma’s Q2 2026 Dividend Raises a Deeper Question About Its Capital Allocation Strategy (RPRX)

Royalty Pharma plc recently approved a second-quarter 2026 dividend of US$0.235 per Class A ordinary share, payable on June 10, 2026, to shareholders of record as of May 15, 2026. This dividend affirmation, alongside increased analyst optimism around upcoming first-quarter 2026 earnings, highlights Royalty Pharma’s focus on cash returns while markets reassess its royalty-driven model and risk profile. We’ll now examine how the confirmed Q2 2026 dividend supports Royalty Pharma’s investment...
NYSE:KAI
NYSE:KAIMachinery

Kadant Profil Deal Expands Industrial Processing Scale And Investor Questions

Kadant has completed the acquisition of voestalpine BÖHLER Profil, which has been renamed Kadant Profil. The deal expands Kadant’s product portfolio and international manufacturing footprint within its Industrial Processing segment. The transaction adds advanced R&D capabilities and industrial knife solutions to Kadant’s offering. Kadant (NYSE:KAI), recently trading around $293.13, has seen mixed share performance, with a 10.2% decline over the past week and a 2.3% gain year to date. Over...
NYSE:ETR
NYSE:ETRElectric Utilities

Entergy (ETR) Earnings Growth And 13.4% Margin Reinforce Bullish Narratives Ahead Of 2026

Entergy (ETR) opened 2026 with Q1 revenue of US$3.2b and basic EPS of US$0.84, against a trailing twelve month EPS figure of US$3.98 that reflects earnings growth of 32.9% over the past year. Over the last five reported quarters, revenue has ranged from US$2.7b to US$3.8b while quarterly EPS has moved between US$0.52 and US$1.55, giving investors a clear view of how the top and bottom lines have tracked through recent periods. With trailing net profit margin now at 13.4% compared with 11.2% a...
NYSE:ST
NYSE:STElectrical

Is It Too Late To Consider Sensata Technologies Holding (ST) After A 98% One Year Rally?

This article examines whether Sensata Technologies Holding, at around US$41.64, is priced for further upside or already reflects most of its story, focusing squarely on what the numbers indicate about value. The stock has returned 18.2% over the last 30 days and 97.8% over the past year. The year-to-date return is 19.3%, while the 5-year return is a 24.0% decline. Recent coverage has highlighted the stock's strong 1-year return of 97.8% and contrasted that with its weaker 5-year record. This...
NasdaqCM:CPRX
NasdaqCM:CPRXBiotechs

Angelini Interest Puts Catalyst Pharmaceuticals Rare Disease Value In Focus

Angelini Pharma is reportedly exploring a potential acquisition of Catalyst Pharmaceuticals, NasdaqCM:CPRX. The rumors center on a possible takeover that could affect Catalyst Pharmaceuticals' valuation and control. The news comes as Catalyst Pharmaceuticals shares last closed at $28.13. Catalyst Pharmaceuticals has delivered strong multi year share returns, with the stock up 21.5% year to date and 15.9% over the past year. Looking further back, investors holding over three and five years...
NasdaqGS:IMKT.A
NasdaqGS:IMKT.AConsumer Retailing

What Ingles Markets (IMKT.A)'s Activist Proxy Win Means For Shareholders

In April 2026, activist investor Summer Road LLC won a contested proxy battle at Ingles Markets, with its nominee Rory A. Held elected to the board following a heated campaign over governance, disclosure, and capital allocation. The result marks a rare successful challenge to a family-influenced grocer’s board, signaling that shareholders were willing to back an outsider aligned with concerns over Ingles’ underused real estate and transparency. We’ll now examine how this board shake-up, and...
NYSE:VEEV
NYSE:VEEVHealthcare Services

Is It Time To Reassess Veeva Systems (VEEV) After A 32% One Year Share Price Slide

If you are wondering whether Veeva Systems at around US$155.97 is starting to look attractively priced, you are not alone. The share price has been under pressure, with a 0.1% slip over the past week, an 11.2% decline over 30 days, a 28.9% decline year to date, and a 32.8% decline over the last year. Recent headlines have focused on how Veeva Systems is positioned within healthcare software and its ability to support life sciences companies with regulated data and workflows. This context...
NYSE:CYD
NYSE:CYDMachinery

Is China Yuchai International (CYD) Still Attractive After A 176% One-Year Share Price Surge?

If you are wondering whether China Yuchai International at around US$41.21 still offers value or if most of the opportunity is already priced in, the starting point is to understand what the recent share price action really reflects. The stock has returned 7.0% over the past 30 days, 11.3% year to date and 175.6% over the last year, while the very large 3 year return and 222.6% 5 year return suggest long term holders have experienced a strong ride through different market conditions. Recent...
NYSE:DG
NYSE:DGConsumer Retailing

Is Dollar General’s (DG) New Retail Media Push Quietly Redefining Its Competitive Moat?

In recent months, Kevel announced a collaboration with Dollar General and The Trade Desk to create a retail media solution that unifies onsite inventory with offsite activation and measurement across the full path to purchase. This move positions Dollar General’s media offering as a more integrated, data-driven platform for advertisers, potentially enhancing the value of its growing digital and advertising capabilities. We’ll now examine how Dollar General’s unified onsite-offsite retail...
NYSE:TEVA
NYSE:TEVAPharmaceuticals

Teva Pharmaceutical (TEVA) Q1 EPS Of US$0.32 Tests Bullish Profitability Narrative

Teva Pharmaceutical Industries (TEVA) opened 2026 with Q1 revenue of US$3.98b and basic EPS of US$0.32, setting the tone for how its earnings story is evolving after a period marked by large one off items. Over recent quarters the company has seen revenue move from US$3.89b in Q1 2025 to US$4.71b in Q4 2025 before landing at US$3.98b in Q1 2026. Basic EPS moved from US$0.19 to US$0.42 and then to US$0.32 over the same stretch, giving you a clear view of how profitability per share has tracked...
NYSE:ASIC
NYSE:ASICInsurance

Ategrity Specialty Insurance (ASIC) Margins And 88.2% Combined Ratio Reinforce Bullish Underwriting Narrative

Ategrity Specialty Insurance Company Holdings (ASIC) kicked off Q1 2026 with total revenue of US$128.9 million and basic EPS of US$0.53, setting the tone for another data rich update for investors. Over the past four reported quarters, revenue has moved from US$83.1 million in Q1 2025 to US$128.9 million in Q1 2026, while basic EPS has shifted from US$0.02 to US$0.53, giving you a clear view of how the top and bottom lines have tracked together across the year. With trailing net profit...
NYSE:NKE
NYSE:NKELuxury

Nike Criticism Over Wages And Taxes Adds To ESG Investment Risks

Nike is under fresh scrutiny as Oregon educators and Asian garment workers jointly call on the company to address alleged supply chain human rights issues and wage theft. Critics are also urging Nike to contribute more to public education funding, questioning the role of historic tax breaks in Oregon. The coordinated appeals raise new environmental, social, and governance, or ESG, questions for Nike beyond previously reported layoffs and internal restructuring. Nike, NYSE:NKE, now faces...